Use of ciprofloxacin in the treatment of brucellosis

  • M. Doğanay
  • B. Aygen
Letters

References

  1. 1.
    Khan MY, Dizon M, Kiel FW Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents againstBrucella melitensis. Antimicrobial Agents and Chemotherapy 1989, 33: 1409–1410.PubMedGoogle Scholar
  2. 2.
    Bosch J, Linares J, Lopez de Goicoechea MJ, Ariza J, Cisnal MC, Martin R In vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains ofBrucella melitensis. Journal of Antimicrobial Chemotherapy 1986, 17: 459–461.PubMedGoogle Scholar
  3. 3.
    Rodriguez JAG, Sanchez JEG, Trujillano I, Bellido JLM In vitro activity of new quinolones againstBrucella melitensis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 992–993.Google Scholar
  4. 4.
    Baykal M, Akalin HE, Firat M, Serin A In vitro activity and clinical efficacy of ofloxacin in infections due toBrucella melitensis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 993–994.Google Scholar
  5. 5.
    Andriole VT Clinical overview of the newer 4-quinolone antibacterial agents. In: Andriole VT (ed): The quinolones. Academic Press, London, 1988, p. 155–200.Google Scholar
  6. 6.
    Salata RA, Ravdin JI Brucella species (Brucellosis). In: Mandell GL, Douglas RG, Bennet JE (ed): Principles and practice of infectious diseases. John Wiley, New York, 1985, p. 1285–1290.Google Scholar
  7. 7.
    Tilton RC, Howard BJ Antimicrobial susceptibility testing. In: Howard BJ, Klaas J, Weissfeld AS, Rubin SJ, Tilton RJ (ed): Clinical and pathogenic microbiology. CV Mosby, Washington, 1987, p. 121–156.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992

Authors and Affiliations

  • M. Doğanay
  • B. Aygen

There are no affiliations available

Personalised recommendations